112 related articles for article (PubMed ID: 11500347)
1. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis.
Hebestreit A; Kersting U; Basler B; Jeschke R; Hebestreit H
Am J Respir Crit Care Med; 2001 Aug; 164(3):443-6. PubMed ID: 11500347
[TBL] [Abstract][Full Text] [Related]
2. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EW
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):129-34. PubMed ID: 9870926
[TBL] [Abstract][Full Text] [Related]
3. [Benzamil and mucoviscidosis. Primary culture of nasal mucosa as an electrophysiologic in vitro model].
Blank U; Glanz H; Eistert B; Fryen A; Lindemann H; Hüls G; Clauss W; Weber WM
HNO; 1996 Apr; 44(4):172-7. PubMed ID: 8655347
[TBL] [Abstract][Full Text] [Related]
4. Hypertonic saline inhibits luminal sodium channels in respiratory epithelium.
Hebestreit A; Kersting U; Hebestreit H
Eur J Appl Physiol; 2007 May; 100(2):177-83. PubMed ID: 17318647
[TBL] [Abstract][Full Text] [Related]
5. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
Middleton PG; House HH
Pediatr Pulmonol; 2010 Aug; 45(8):789-95. PubMed ID: 20597077
[TBL] [Abstract][Full Text] [Related]
6. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
Middleton PG; Geddes DM; Alton EW
Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
[TBL] [Abstract][Full Text] [Related]
7. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis.
Cotton CU; Stutts MJ; Knowles MR; Gatzy JT; Boucher RC
J Clin Invest; 1987 Jan; 79(1):80-5. PubMed ID: 3793933
[TBL] [Abstract][Full Text] [Related]
8. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
Mall M; Bleich M; Greger R; Schreiber R; Kunzelmann K
J Clin Invest; 1998 Jul; 102(1):15-21. PubMed ID: 9649552
[TBL] [Abstract][Full Text] [Related]
9. A multicenter study of the effect of solution temperature on nasal potential difference measurements.
Boyle MP; Diener-West M; Milgram L; Knowles M; Foy C; Zeitlin P; Standaert T;
Chest; 2003 Aug; 124(2):482-9. PubMed ID: 12907532
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology of ion channels in mucoviscidosis. Physiological bases and therapeutic applications].
Danner I; Baro-Puigdemasa I; Escande D
Rev Pneumol Clin; 1995; 51(3):186-92. PubMed ID: 7569582
[TBL] [Abstract][Full Text] [Related]
11. Relative ion permeability of normal and cystic fibrosis nasal epithelium.
Knowles M; Gatzy J; Boucher R
J Clin Invest; 1983 May; 71(5):1410-7. PubMed ID: 6853720
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor inhibits amiloride-sensitive Na(+) channel function in cystic fibrosis airway epithelium in vitro.
Shen BQ; Widdicomb JH; Mrsny RJ
Pulm Pharmacol Ther; 1999; 12(3):157-64. PubMed ID: 10419835
[TBL] [Abstract][Full Text] [Related]
13. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis.
Sweezey NB; Smith D; Corey M; Ellis L; Carpenter S; Tullis DE; Durie P; O'Brodovich HM
Pediatr Pulmonol; 2007 Jun; 42(6):519-24. PubMed ID: 17469152
[TBL] [Abstract][Full Text] [Related]
14. Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma.
Schmitt L; Wiebel M; Frese F; Dehnert C; Zugck C; Bärtsch P; Mairbäurl H
Eur Respir J; 2011 Feb; 37(2):342-8. PubMed ID: 20525718
[TBL] [Abstract][Full Text] [Related]
15. A modified technique for measurement of nasal transepithelial potential difference in infants.
Southern KW; Noone PG; Bosworth DG; Legrys VA; Knowles MR; Barker PM
J Pediatr; 2001 Sep; 139(3):353-8. PubMed ID: 11562613
[TBL] [Abstract][Full Text] [Related]
16. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
Knowles M; Gatzy J; Boucher R
N Engl J Med; 1981 Dec; 305(25):1489-95. PubMed ID: 7300874
[TBL] [Abstract][Full Text] [Related]
17. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.
Hofmann T; Stutts MJ; Ziersch A; Rückes C; Weber WM; Knowles MR; Lindemann H; Boucher RC
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1844-9. PubMed ID: 9620916
[TBL] [Abstract][Full Text] [Related]
18. [Status of determining the transepithelial potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis].
Unal-Maelger OH; Urbanek R
Monatsschr Kinderheilkd; 1988 Feb; 136(2):76-80. PubMed ID: 2452977
[TBL] [Abstract][Full Text] [Related]
19. Colonic and esophageal transepithelial potential difference in cystic fibrosis.
Orlando RC; Powell DW; Croom RD; Berschneider HM; Boucher RC; Knowles MR
Gastroenterology; 1989 Apr; 96(4):1041-8. PubMed ID: 2925051
[TBL] [Abstract][Full Text] [Related]
20. Modified method to measure nasal potential difference.
Leal T; Lebacq J; Lebecque P; Cumps J; Wallemacq P
Clin Chem Lab Med; 2003 Jan; 41(1):61-7. PubMed ID: 12636051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
